Muscular Dystrophy Articles & Analysis
15 articles found
The balance of inflammatory and anti-inflammatory signals produced by SMECs is crucial, as dysregulation can lead to chronic inflammation, often associated with conditions such as muscular dystrophy and other muscle-wasting diseases. Beyond their roles in blood flow regulation and inflammation, SMECs contribute to metabolic functions within skeletal muscle. ...
Therapeutics: Developing gene therapies for diseases caused by cytoskeletal malfunctions (e.g., certain muscular dystrophies). ·Intracellular Sensors and Biosensors Developing intracellular sensors and biosensors has enabled real-time monitoring of the cytoskeletal dynamics. ...
By designing custom mRNA molecules, researchers can steer stem cell differentiation towards specific cell types, offering promising prospects in treating conditions such as spinal cord injuries and muscular dystrophy. This precision in directing cell development has the potential to revolutionize the field of regenerative medicine, providing new avenues for ...
Many variants of AAV exist, each having unique properties that make them suitable for distinct applications, from ocular gene therapy to curing muscular dystrophy, hemophilia, and other genetic diseases. However, despite these promising attributes, the AAV formulation development process is not without its challenges. ...
Walker-Warburg syndrome, acute leukemia and muscular dystrophy-dystroglycanopathy, type a, 1 are all related to chromosome 9 inversion. ...
Currently, several siRNA drugs for rare diseases have been approved for marketing, such as: Patisiran (Hereditary trans thyroxine amyloidosis, ATTR) Exondys51 (Duchenne muscular dystrophy, DMD) Givosiran (Acute intermittent porphyria, AIP) Inclisiran (Hyperlipidemia) Tivanisiran (Dry eye syndrome, DES) QPI-1007 (Optic atrophy) SYL040012 (Glaucoma) QPI-1002 ...
Researchers at Tel Aviv University's Laboratory of Precision NanoMedicine developed an LNP-based CRISPR-Cas9 mRNA delivery system for the treatment of Duchenne Muscular Dystrophy (DMD) caused by functional loss-of-function mutations in the dystrophin gene. ...
Development of Baculovirus Vectors Safe and effective baculovirus vectors for gene delivery can help accelerate the development of gene therapies for a number of rare diseases such as Duchenne muscular dystrophy (DMD). Development of Alphavirus Vectors Develop alphavirus vectors with reduced cytotoxicity and enhanced gene expression capacity to enable effective ...
Abnormalities in muscle function are observed in many inherited or acquired diseases, such as muscular dystrophy, chronic obstructive pulmonary disease, and congestive heart failure. ...
Accidents like car crashes are a fairly common cause of tetraplegia. Muscular dystrophy: Muscular dystrophy is not the name of one particular disease, but rather a common term for the group of diagnoses that cause progressive weakness and loss of muscle mass. ...
Name (Trade Name) Disease Drug Category Company Approval Year Fomvirsen(Vitravene) Tile cell virus retinitis Antisense oligonucleotide lonas Novartis 1998 Pegaptanib(Macugen) age-related macular degeneration Aptamer NeXstarEyelech 2004 Mipomersen(Kynamro) hoFH Antisense oligonucleotide loais Genryme 2013 Defibrotide(Definelio) HVOD Antisense oligonucleotide Jazz 2016 Eteplirsen(Exondys 51) ...
As such, the water was seen to improve the muscular dystrophy in patients. Prevention of metabolic syndrome Fatty liver was reduced during tests on mice with diabetes as well as obesity in the mice that had a fatty liver as a result of a fat diet. ...
ByOlansi
As such, the water was seen to improve the muscular dystrophy in patients. Prevention of metabolic syndrome Fatty liver was reduced during tests on mice with diabetes as well as obesity in the mice that had a fatty liver as a result of a fat diet. ...
ByOlansi
Insufficient Vitaman E—which develops muscle tissue—causes nutritional muscular dystrophy, the degeneration of muscle tissue, also known as white muscle disease. ...
In addition to this study, there is also a physiologist at the University of Buffalo attempting to heal muscular dystrophy patients with a chemical compound in the venom of a South American spider (see “Good Venom“). ...